COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 6, 2007, Pages

  Matzdorf, Corina ^a   Kurtz, A ^a   Höcherl, Klaus ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cyclooxygenase; Isoproterenol; Prostaglandins; Renovascular hypertension; SC 58236

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; ANGIOTENSIN II; CANDESARTAN HEXETIL; CAPTOPRIL; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FUROSEMIDE; ISOPRENALINE; MESSENGER RNA; PROSTAGLANDIN E2; RAMIPRIL; RENIN; RNA; SEVOFLURANE; 4 (5 (4 CHLOROPHENYL) 3 (TRIFLUOROMETHYL) 1H PYRAZOL 1 YL)BENZENESULFONAMIDE; 4-(5-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIURETIC AGENT; PROSTAGLANDIN; PYRAZOLE DERIVATIVE; SODIUM; SULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; KIDNEY; KIDNEY ARTERY STENOSIS; KIDNEY CORTEX; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RAT; RENAL ARTERY; RODENT; SALT INTAKE; UPREGULATION; URINARY EXCRETION; ANIMAL; BIOSYNTHESIS; BLOOD; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; RENOVASCULAR HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DIURETICS; FUROSEMIDE; GENE EXPRESSION REGULATION; HYPERTENSION, RENOVASCULAR; ISOPROTERENOL; KIDNEY; MALE; PROSTAGLANDINS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RENIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM; SULFONAMIDES; UP-REGULATION;

EID: 34447646732     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00513.2006     Document Type: Article

References (39)

1. Campbell WB, Jackson EK, Graham RM. Saralasin-induced renin release: its blockade by prostaglandin synthesis inhibitors in the conscious rat. Hypertension 1: 637-642, 1979.
2. Castrop H, Kammerl M, Mann B, Jensen BL, Krämer BK, Kurtz A. Cyclooxygenase 2 and neuronal nitric oxide synthase expression in the renal cortex are not interdependent in states of salt deficiency. Pflügers Arch 441: 235-240, 2000.
3. Castrop H, Schweda F, Schumacher K, Wolf K, Kurtz A. Role of renocortical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion. J Am Soc Nephrol 12: 867-874, 2001.
4. Chen M, Schnermann J, Malvin RL, Killen PD, Briggs JP. Time course of stimulation of renal renin messenger RNA by furosemide. Hypertension 21: 36-41, 1993.
5. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, Harris RC. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest 103: 953-961, 1999.
6. Cheng HF, Wang JL, Zhang MZ, Wang SW, McKanna JA, Harris RC. Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition. Am J Physiol Renal Physiol 280: F449-F456, 2001.
7. Francisco LL, Osborn JL, DiBona GF. Prostaglandin in renin release during sodium deprivation. Am J Physiol Renal Fluid Electrolyte Physiol 243: F537-F542, 1982.
8. Fujino T, Nakagawa N, Yuhki K, Hara A, Yamada T, Takayama K, Kuriyama S, Hosoki Y, Takahata O, Taniguchi T, Fukuzawa J, Hasebe N, Kikuchi K, Narumiya S, Ushikubi F. Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP. J Clin Invest 114: 805-812, 2004.
9. Gerber JG, Keller RT, Nies AS. Prostaglandins and renin release: the effect of PGI2, PGE2, and 13,14-dihydro PGE2 on the baroreceptor mechanism of renin release in the dog. Circ Res 44: 796-799, 1979.
10. Greenberg SG, Lorenz JN, He XR, Schnermann JB, Briggs JP. Effect of prostaglandin synthesis inhibition on macula densa-stimulated renin secretion. Am J Physiol Renal Fluid Electrolyte Physiol 265: F578-F583, 1993.
11. Hackenthal E, Paul M, Ganten D, Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 70: 1067-1116, 1990.
12. Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281: F1-F11, 2001.
13. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94: 2504-2510, 1994.
14. Hartner A, Cordasic N, Goppelt-Struebe M, Veelken R, Hilgers KF. Role of macula densa cyclooxygenase-2 in renovascular hypertension. Am J Physiol Renal Physiol 284: F498-F502, 2003.
15. Henrich WL, Campbell WB. The systemic beta-adrenergic pathway to renin secretion: relationships with the renal prostaglandin system. Endocrinology 113: 2247-2254, 1983.
16. Höcherl K, Endemann D, Kammerl MC, Grobecker HF, Kurtz A. Cyclo-oxygenase-2 inhibition increases blood pressure in rats. Br J Pharmacol 136: 1117-1126, 2002.
17. Höcherl K, Kammerl M, Kees F, Krämer BK, Grobecker HF, Kurtz A. Role of renal nerves in stimulation of renin, COX-2, and nNOS in rat renal cortex during salt deficiency. Am J Physiol Renal Physiol 282: F478-F484, 2002.
18. Höcherl K, Kammerl MC, Schumacher K, Endemann D, Grobecker HF, Kurtz A. Role of prostanoids in regulation of the renin-angiotensin- aldosterone system by salt intake. Am J Physiol Renal Physiol 283: F294-F301, 2002.
19. Höcherl K, Wolf K, Castrop H, Ittner KP, Bucher M, Kees F, Grobecker HF, Kurtz A. Renocortical expression of renin and of cyclooxygenase-2 in response to angiotensin II AT1 receptor blockade is closely coordinated but not causally linked. Pflügers Arch 442: 821-827, 2001.
20. Holmer SR, Kaissling B, Putnik K, Pfeifer M, Krämer BK, Riegger GA, Kurtz A. Beta-adrenergic stimulation of renin expression in vivo. J Hypertens 15: 1471-1479, 1997.
21. Jensen BL, Schmid C, Kurtz A. Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells. Am J Physiol Renal Fluid Electrolyte Physiol 271: F659-F669, 1996.
22. Khan KN, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ. Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney Int 61: 1210-1219, 2002.
23. Kim SM, Chen L, Mizel D, Huang YG, Briggs JP, Schnermann JB. Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice. Am J Physiol Renal Physiol 292: F418-F422, 2007.
24. Kopp U, DiBona GF. Interaction of renal β1-adrenoceptors and prostaglandins in reflex renin release. Am J Physiol Renal Fluid Electrolyte Physiol 244: F418-F424, 1983.
25. Mann B, Hartner A, Jensen BL, Hilgers KF, Höcherl K, Krämer BK, Kurtz A. Acute upregulation of COX-2 by renal artery stenosis. Am J Physiol Renal Physiol 280: F119-F125, 2001.
26. Mann B, Hartner A, Jensen BL, Kammerl M, Krämer BK, Kurtz A. Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int 59: 62-68, 2001.
27. Muscara MN, Vergnolle N, Lovren F, Triggle CR, Elliott SN, Asfaha S, Wallace JL. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br J Pharmacol 129: 1423-1430, 2000.
28. Richter CM, Godes M, Wagner C, Maser-Gluth C, Herzfeld S, Dorn M, Priem F, Slowinski T, Bauer C, Schneider W, Neumayer HH, Kurtz A, Hocher B. Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats. J Hypertens 22: 191-198, 2004.
29. Rodriguez F, Llinas MT, Gonzalez JD, Rivera J, Salazar FJ. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Hypertension 36: 276-281, 2000.
30. Roig F, Llinas MT, Lopez R, Salazar FJ. Role of cyclooxygenase-2 in the prolonged regulation of renal function. Hypertension 40: 721-728, 2002.
31. Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 66: 76-84, 1999.
32. Schnermann J. Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol Regul Integr Comp Physiol 274: R263-R279, 1998.
33. Schricker K, Hamann M, Kaissling B, Kurtz A. Renal autacoids are involved in the stimulation of renin gene expression by low perfusion pressure. Kidney Int 46: 1330-1336, 1994.
34. Schweda F, Kurtz A. Cellular mechanism of renin release. Acta Physiol Scand 181: 383-390, 2004.
35. Traynor TR, Smart A, Briggs JP, Schnermann J. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2. Am J Physiol Renal Physiol 277: F706-F710, 1999.
36. Villarreal D, Davis JO, Freeman RH, Sweet WD, Dietz JR. Effects of meclofenamate on the renin response to aortic constriction in the rat. Am J Physiol Regul Integr Comp Physiol 247: R546-R551, 1984.
37. Wang JL, Cheng HF, Harris RC. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34: 96-101, 1999.
38. Yang T, Endo Y, Huang YG, Smart A, Briggs JP, Schnermann J. Renin expression in COX-2-knockout mice on normal or low-salt diets. Am J Physiol Renal Physiol 279: F819-F825, 2000.
39. Yang T, Huang YG, Ye W, Hansen P, Schnermann JB, Briggs JP. Influence of genetic background and gender on hypertension and renal failure in COX-2-Deficient mice. Am J Physiol Renal Physiol 288: F1125-F1132, 2005.